These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7999439)

  • 1. [Intracranial tumors and T lymphocytes].
    Nitta T
    No To Shinkei; 1994 Sep; 46(9):823-33. PubMed ID: 7999439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitumor immune reactions in lymphoma].
    Bagot M
    Ann Dermatol Venereol; 1998 Sep; 125(9):628-9. PubMed ID: 9805558
    [No Abstract]   [Full Text] [Related]  

  • 3. B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.
    Ando H; Saio M; Ohe N; Tamakawa N; Yu H; Nakayama T; Yoshimura S; Kaku Y; Iwama T; Shinoda J; Sakai N; Takami T
    Int J Oncol; 2002 Apr; 20(4):807-12. PubMed ID: 11894129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
    Ferradini L; Mackensen A; Genevée C; Bosq J; Duvillard P; Avril MF; Hercend T
    J Clin Invest; 1993 Mar; 91(3):1183-90. PubMed ID: 8450047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function.
    Chambers WH; Bozik ME; Brissette-Storkus SC; Basse P; Redgate E; Watkins S; Boggs SS
    Cancer Res; 1996 Aug; 56(15):3516-25. PubMed ID: 8758920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.
    Lockhart DC; Chan AK; Mak S; Joo HG; Daust HA; Carritte A; Douville CC; Goedegebuure PS; Eberlein TJ
    Surgery; 2001 Jun; 129(6):749-56. PubMed ID: 11391375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.
    Plautz GE; Touhalisky JE; Shu S
    Cell Immunol; 1997 Jun; 178(2):101-7. PubMed ID: 9225000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
    Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
    J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.
    Kjaergaard J; Tanaka J; Kim JA; Rothchild K; Weinberg A; Shu S
    Cancer Res; 2000 Oct; 60(19):5514-21. PubMed ID: 11034096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(3A):1759-68. PubMed ID: 10928105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identical T-cell receptor transcripts in multiple melanoma metastases.
    Schrama D; Fuchs E; Bröcker EB; Thor Straten P; Becker JC
    Cancer Res; 2002 Oct; 62(20):5664-7. PubMed ID: 12384521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
    Inoue M; Plautz GE; Shu S
    Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
    Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.
    Morford LA; Elliott LH; Carlson SL; Brooks WH; Roszman TL
    J Immunol; 1997 Nov; 159(9):4415-25. PubMed ID: 9379040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
    Jantzer P; Schendel DJ
    Cancer Res; 1998 Jul; 58(14):3078-86. PubMed ID: 9679974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.